1880 Century Park East
Suite 1000
Los Angeles, California 90067
(310) 203-1000
November 29, 2018
VIA EDGAR
United States Securities and Exchange Commission
100 F Street, NE
Washington, D.C. 20549
Attention: Christine Westbrook
| Re: | Ritter Pharmaceuticals, Inc. – Request for Acceleration | |
| Registration Statement on Form S-3 | ||
| File No. 333-228501 |
Dear Ms. Yale:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Ritter Pharmaceuticals, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-228501) (the “Registration Statement”), so that it may become effective at 5:00 p.m. Eastern Standard Time on Friday, November 30, 2018, or as soon thereafter as practicable.
The Registrant hereby authorizes each of Aron Izower, Esq. and Wendy Grasso, Esq. of Reed Smith LLP, attorneys for the Registrant, to orally modify or withdraw this request for acceleration.
The Registrant requests that it be notified of such effectiveness by a telephone call to Aron Izower at (212) 549-0393 or, in his absence, Wendy Grasso at (212) 549-0216.
| RITTER PHARMACEUTICALS, INC. | ||
| /s/ John W. Beck | ||
| By: | John W. Beck | |
| Chief Financial Officer | ||